News from Relburn-Metabolomics, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 11, 2017, 07:31 ET Relburn-Metabolomics to Present Developments in Lead Programs for NASH and Gout

Relburn-Metabolomics, Inc. announced that the Company will update scientific findings and clinical development plans for its drug...


Oct 06, 2017, 07:35 ET Relburn-Metabolomics Appoints Renowned Experts in Nonalcoholic Steatohepatitis (NASH) to its Scientific Advisory Board

Relburn-Metabolomics, Inc. announced the appointment of two highly regarded specialists in liver disease to its Scientific Advisory Board. The new...


Oct 17, 2016, 08:10 ET Relburn-Metabolomics Files Patents on Bifunctional Nanomolar Inhibitors of Gout Target Enzymes

Relburn-Metabolomics, Inc. announced that the Company has achieved key milestones in finalizing its medicinal chemistry program that targets...


Oct 20, 2015, 08:05 ET Relburn-Metabolomics to Outline Research Progress at BIO Investor Forum

 Relburn-Metabolomics, Inc. announced that the Company has been selected to present at the annual BIO Investor Forum taking place in San...